The Zacks Analyst Blog Highlights Visa, Advanced Micro Devices and Thermo Fisher Scientific

Zacks highlights Visa, AMD and Thermo Fisher as top analyst picks, noting Visa’s FY25 total revenue growth of 11% year-over-year and 13% cross-border growth driven by volume and digital payments initiatives while flagging rising client incentives, higher FY26 adjusted costs (~11% expected) and regulatory risk. AMD shares have surged ~91.3% over the past year on strong EPYC and Instinct demand and new MI350 offerings that bolster cloud and AI deployments, though competition from NVIDIA and Intel remains a material headwind. Thermo Fisher has outperformed peers (+12.4% year) with product innovation, OpenAI integration and the Solventum acquisition supporting a Zacks-modeled 5.1% revenue CAGR through 2025–2027, but carries leverage, policy-driven academic/government softness and currency exposure as key risks.

Analysis

Market structure: AI-driven demand for data-center compute is a clear winner — AMD (EPYC + Instinct) and their OEM partners (HPE, Dell, Supermicro) gain share versus incumbents that miss design wins. Visa benefits from durable volume growth and cross-border recovery but faces margin pressure from client incentives (Zacks flags ~11% FY26 cost rise); smaller payments firms and legacy card rails without scaleable token/stablecoin infrastructure are the laggards. Pricing power will bifurcate: hyperscalers can demand discounts but motive to vertically integrate and buy whole-system solutions favors AMD’s system-level push.

Risk assessment: Tail risks include (1) regulatory action on interchange/fee structures hitting Visa within 6–18 months, (2) foundry-capacity shocks or TSMC allocation shifts constraining AMD over the next 3–12 months, and (3) a sharper-than-expected academic/government funding pullback compressing Thermo Fisher (TMO) revenues and stressing refinancing (watch net debt/EBITDA >3.5x as a red flag). Short-term (days–weeks) volatility will be driven by earnings beats/misses and capex guides; long-term (2–5 years) outcomes hinge on AI adoption curves and software ecosystem wins.

Trade implications: Favor tactical long exposure to AMD into the next 2–6 months sized 1–3% of portfolio, hedged with cheap put spreads to limit a 20–30% downside. For Visa, use buy-on-dip discipline: accumulate 1–2% positions only if price drops >8–12% or if FY26 adjusted cost guidance exceeds +11%; consider covered-call overlays to monetize carry. Avoid outright long TMO equities until two consecutive quarters of >3% organic growth or leverage improvement; prefer selective credit exposure if bond spreads widen >50bps.

Contrarian angles: Consensus may underprice AMD’s secular CPU share gains — a 10–20% upside over 12 months if EPYC wins at three largest hyperscalers continue — but may be overestimating Thermo’s quick recovery given policy and FX headwinds. Visa’s regulatory risk is under-hedged in equities; a 6–12 month legislative push could re-rate multiples by 10–25%. Watch for concentration risk: a single hyperscaler change of vendor preference would be a rapid profit inflection for AMD and should be treated as high-impact monitoring item.

Key Decisions for Investors

• Establish a 1.5–3% long position in AMD (AMD) over the next 2–6 weeks to capture EPYC/Instinct server traction; hedge with a 3-month 15% OTM put spread sized to limit portfolio drawdown to ~25% of the position.
• Add a 1–2% tactical long in Visa (V) on weakness: only accumulate if shares drop >8% from current levels or if the stock trades below its 50-day MA; implement covered-call sales (30–60 day calls) to generate 2–4% annualized carry while monitoring FY26 adjusted cost guidance — reduce position if guidance >11% or if regulatory headlines intensify.
• Do not initiate new large-cap long positions in Thermo Fisher (TMO) until demonstration of operational deleverage — wait for two consecutive quarters of organic revenue growth >3% YoY or net debt/EBITDA falling below 3.5x; alternatively, buy TMO corporate bonds or 3–5 year CDS protection if spreads widen >50bps as a cheaper way to express idiosyncratic credit exposure.
• Implement a pair trade: long AMD 1–2% vs short Intel (INTC) 0.8–1% (or short the most overextended GPU-equity exposure) to express secular CPU/accelerator share shift; rebalance if relative performance diverges by ±15% or after quarterly results confirm design wins.
• Monitor these catalysts closely over 30–90 days: hyperscaler capex guides (positive trigger: consolidated cloud capex beats by >5%), AMD foundry-share headlines (negative trigger: TSMC allocation cut >10%), and any US interchange fee/regulatory proposals (negative trigger: bipartisan bill proposing >15% fee cap).